Erasca
phase patients continuing on treatment on potential for confirmation of dor and advantage in seacraft | Erasca
Company
Deck Type
Sector
Industry
Deck date
August 2023
Slide
21 of 56
Similar slides by Erasca
See diffirences between slides (animation)
Investor Presentation
November 2023
phase patients continuing on treatment on potential for confirmation of dor and advantage in seacraft | Erasca
Related slides by other companies
BioAtla
Investor Presentation
January 2024
phase cab demographics tumor types | BioAtla
Fusion Pharmaceuticals
Investor Presentation
January 2024
program milestones patients | Fusion Pharmaceuticals
Equillium
Investor Presentation
December 2023
clinically validated in severe dermatological disease | Equillium
BioNTech
Results
November 2020
phase a safety profile | BioNTech
Other recent decks by Erasca
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
IPO
July 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io